LLY compared with AMRX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

AMRXAmneal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only AMRX 14

—Customer Aunlistedcustomer

—Kashiv Biosciencesunlistedsupplier

—ApiJect Systemsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

BIAL-Portela & Ca

unlistedsupplier

10 more · AMRX chain ›

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

AMRXAmneal Pharmaceuticals, Inc.

19.45▼−2.51%· post 19.73

ClosedNov 5 '26

Mkt cap$6.4BRevenue$796MQ2 FY26Revenue$3.0BFY25

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

AMRXAmneal Pharmaceuticals, Inc.

1,371.32▼−3.29%post 1,363.77

Price

19.45▼−2.51%post 19.73

$1.2T

Mkt cap

$6.4B

Q3 FY26$24.4B

Revenue

$796MQ2 FY26

FY25$65.2B

Revenue

$3.0BFY25

LLY1,371.32▼−3.29%vsAMRX19.45▼−2.51%ClosedNov 5 '26